Stephen J Tulipano's Net Worth
$4.4 Million
Who is Stephen J Tulipano?
Stephen J Tulipano has an estimated net worth of $4.4 Million. This is based on reported shares across multiple companies, which include Stoke Therapeutics, Inc., Aldeyra Therapeutics, Inc., and JAVELIN PHARMACEUTICALS, INC.
SEC CIK
Stephen J Tulipano's CIK is 0001360548
Past Insider Trading and Trends
2009 was Stephen J Tulipano's most active year for acquiring shares with 5 total transactions. Stephen J Tulipano's most active month to acquire stocks was the month of February. 2020 was Stephen J Tulipano's most active year for disposing of shares, totalling 10 transactions. Stephen J Tulipano's most active month to dispose stocks was the month of October. 2020 saw Stephen J Tulipano paying a total of $313,600.00 for 130,000 shares, this is the most they've acquired in one year. In 2021 Stephen J Tulipano cashed out on 60,000 shares for a total of $1,765,895.79, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Stoke Therapeutics, Inc. (STOK) Snapshot price: $14.7
Former CFO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 27
| |||
Form 4
| +76.38% | 8.98K |
$6.10 | -$25,101.84 | 20.75K |
Mar 15 - Mar 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 7
| |||
Form 4
| +1,853.82% | 11.16K |
$4.48 | $49,996.80 | 11.76K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
$31.67 | -$1,631,495.79 | 602 |
Scheduled
|
Feb 22 - Feb 23
| ||
Form 4
|
—
|
0
|
$21.74 | -$2,416,338.53 | 602 |
Scheduled
|
Nov 2 - Nov 4
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Aldeyra Therapeutics, Inc. (ALDX) Snapshot price: $6.13
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +156.92% | 5.23K |
$3.98 | $20,805.58 | 8.56K |
Jun 30 - Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
∞
| 3.33K |
$4.50 | $14,998.50 | 3.33K |
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
JAVELIN PHARMACEUTICALS, INC No price found
CFO and Secretary
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -22.61K |
$2.20 | -$49,753.00 |
0
|
Jun 30 - Jul 2
| |||
Form 4
| -9.54% | -2.38K |
$2.18 | -$5,199.54 | 22.61K |
May 3
| |||
Form 4/A
| +66.67% | 10K |
—
|
—
| 25K |
Dec 18
| |||
Form 4
| +66.67% | 10K |
—
|
—
| 25K |
Dec 18
| |||
Form 4
|
∞
| 15K |
—
|
—
| 15K |
May 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |